Articles published by Median Technologies

< Previous 1 2 3 Next >

Median Technologies to Participate in the Cowen’s 43rd Annual Health Care Conference

February 23, 2023

From Median Technologies

Via Business Wire

Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023

January 24, 2023

From Median Technologies

Via Business Wire

Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million

January 19, 2023

From Median Technologies

Via Business Wire

Median Technologies: Financial Communications Schedule for the First Half of 2023

December 21, 2022

From Median Technologies

Via Business Wire

Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations

November 22, 2022

From Median Technologies

Via Business Wire

Median Technologies Announces Its 2022 Half-year Results and Revenues for the Third Quarter

October 20, 2022

From Median Technologies

Via Business Wire

Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening

October 03, 2022

From Median Technologies

Via Business Wire

Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy®

September 06, 2022

From Median Technologies

Via Business Wire

Median Technologies: Financial Communication Schedule for the Second Half of 2022

July 25, 2022

From Median Technologies

Via Business Wire

Median Technologies Communicates Its Business Indicators for the Second Quarter of 2022

July 11, 2022

From Median Technologies

Via Business Wire

Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy®

July 08, 2022

From Median Technologies

Via Business Wire

Median Technologies to host a live webcast and provide a company update on July 12, 2022

July 07, 2022

From Median Technologies

Via Business Wire

Bryan Garnier & Co Initiates the Coverage of Median Technologies with a “Buy” Recommendation

June 13, 2022

From Median Technologies

Via Business Wire

Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA

June 02, 2022

From Median Technologies

Via Business Wire

Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy® Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials

May 31, 2022

From Median Technologies

Via Business Wire

Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022

May 23, 2022

From Median Technologies

Via Business Wire

Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device

May 05, 2022

From Median Technologies

Via Business Wire

Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022

April 21, 2022

From Median Technologies

Via Business Wire

Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022

March 25, 2022

From Median Technologies

Via Business Wire

Median Technologies Announces Design Completion of its iBiopsy® Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance

March 22, 2022

From Median Technologies

Via Business Wire

Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million

January 17, 2022

From Median Technologies

Via Business Wire

Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy® Lung Cancer Screening

January 05, 2022

From Median Technologies

Via Business Wire

Median Technologies: Financial Communications Schedule for the First Half of 2022

January 04, 2022

From Median Technologies

Via Business Wire

Median Technologies Announces New Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization

November 23, 2021

From Median Technologies

Via Business Wire

Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators

October 21, 2021

From Median Technologies

Via Business Wire

Median Technologies to Host a Live Webcast and Provide a Company Update on October 25th, 2021

October 13, 2021

From Median Technologies

Via Business Wire

Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications

September 16, 2021

From Median Technologies

Via Business Wire

Median Technologies Changes the Publication Date of Its H1 2021 Results

September 14, 2021

From Median Technologies

Via Business Wire

Median Technologies Announces Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 to Accurately Characterize Malignant vs Benign Lung Nodules Based on a Large-scale Patient Cohort

September 06, 2021

From Median Technologies

Via Business Wire

Median Technologies Appoints Jean-Christophe Montigny as Chief Financial Officer and Member of the Executive Committee

July 29, 2021

From Median Technologies

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.